Inclusion Criteria:  Finished one of the following types of chemotherapy: paclitaxel, docetaxel, oxaliplatin, cisplatin, vincristine, thalidomide and/or bortezomib. Diagnosed with CIPN Age 18 years or above Have no documented or observable psychiatric or neurological disorders that might interfere with study participation (e.g., dementia or psychosis) Dutch-speaking Signed informed consent  Exclusion Criteria:  Taking stable doses of medication on prescription for peripheral neuropathy. Related medications are: gabapentin, pregabalin (Lyrica), nortriptyline, amitriptyline, duloxetine (Cymbalta), and venlafaxine. Severe or unstable cardio- respiratory or musculoskeletal disease Interruption of more than two consecutive laser treatments Dark brown or black skin pigmentation (described as skin type VI in the Fitzpatrick scale)